Telehealth Companies Prescribing Unapproved GLP-1s for Addiction

Some telehealth platforms are reportedly prescribing GLP-1 drugs for addiction, despite these medications lacking FDA approval for such use. Clinical trials for this indication are ongoing, raising concerns among experts about patients weighing risks and benefits without full regulatory clearance.